Barbara Leyman
Chief Business Dev. Officer, Sutro Biopharma.
Companies
- Sutro BiopharmaChief Business Dev. Officer Jul 10, 2024 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Sutro Biopharma STRO16,056 shares2$181.1K at $11.28Jul 8, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Jul 8, 2025Shares withheld for tax 8,944 shares at $0.78 of Sutro Biopharma2
- Jul 8, 2025Exercised options 25,000 shares of Sutro Biopharma2
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2